Lead Sponsor

University Hospital Schleswig-Holstein

Age

18 - 80 years

Sex

ALL

Healthy Volunteers

Yes

•IBS according to the Rome III criteria moderate/severe refractory daily symptoms \>1year (FGID-C1) sub classified as IBS-D, constipation predominant (IBS-C) or mixed type (IBS-M) no past infection to trigger symptom no structural/ biochemical cause of their symptoms identified negative gastroscopy, colonoscopy including histology Worsening symptoms after meals various exclusion diets - ineffective females not menstruating during CLE no known allergy to methylene blue or fluorescein Age \>18 years Negative routine testing for food intolerance (or known lactose/fructose intolerance) Positive informed consent

•no consent known reason for the abdominal pain and bloating other than lactose/fructose intolerance M. Whipple Known infectious gastrointestinal disease Stricture in the upper gastrointestinal tract Age \<18years Impaired renal function (Creatinine \>1.2 mg/dL) Pregnancy or breast-feeding Inability to obtain informed consent Active GI Bleeding Known allergy to Methylene blue or Fluorescein Participation in other clinical trials within the last 4 weeks

Related studies

NCT07540312 · IBS (Irritable Bowel Syndrome)

NCT06681012 · Irritable Bowel Syndrome (IBS), Irritable Bowel Syndrome of Diarrhea Type (IBS-D)

NCT01912313 · IBS, Healthy

NCT07481422 · Irritable Bowel Syndrome (IBS)

NCT07089420 · IBD (Inflammatory Bowel Disease), IBS - Irritable Bowel Syndrome, and more

Confocal Laser Endomicroscopy in IBS Patients